# Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

> **NCT00388349** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 146 (actual)

## Conditions studied

- Hodgkin Disease
- Hodgkin's Lymphoma
- Lymphoma

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Vinorelbine
- **DRUG:** Carmustine
- **DRUG:** Etoposide
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Autologous HCT

## Key facts

- **NCT ID:** NCT00388349
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2008-03
- **Final completion:** 2010-09
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2017-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00388349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00388349, "Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00388349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*